Enovix Q2 Revenue Hits High End of Guidance; Smartphone Qualification Nears Completion
ENVX sits 24% above its 52-week low of $3.67.
Summary
Enovix reported Q2 revenue at the high end of guidance, confirmed a key smartphone battery qualification milestone, and guided to a sharp ramp in smart eyewear shipments.
Key Events · Earnings and Guidance · ENVX
-
Q2 Revenue at High End of Guidance
Revenue of $9.0 million, up 21% year-over-year and 19% sequentially, marking the fifth consecutive quarter of year-over-year growth.
-
Smartphone Qualification Milestone
Lead smartphone customer confirmed Enovix batteries passed more than 1,000 cycles under the 0.2C discharge test; final accelerated cycle-life test is underway with completion expected in Q4 2026.
-
Smart Eyewear Ramp Accelerates
Shipped approximately 2,100 AI-1 batteries in Q2 and recognized initial revenue; Q3 shipments expected to increase approximately 9x to 19,000 packs against a 50,000-pack order.
-
Drone and Defense Pipeline Expands
Global pipeline grew 41% to $183 million, driven by drone opportunities that exceeded $100 million during the quarter.
Analysis · ENVX · Manufacturing
Enovix delivered Q2 revenue of $9.0 million, up 21% year-over-year and at the high end of guidance, marking its fifth consecutive quarter of growth. The lead smartphone customer confirmed passing a critical 1,000-cycle test, and the final accelerated cycle-life test is underway with completion expected in Q4 2026 — a key step toward commercial smartphone qualification. Smart eyewear shipments are ramping sharply, with Q3 volumes expected to jump roughly 9x to 19,000 packs. The drone and defense pipeline expanded 41% to $183 million, driven by drone opportunities exceeding $100 million. With $552 million in cash, the company has ample runway to fund qualification and scale-up, though it continues to burn cash with a non-GAAP net loss of $0.13 per share.
At the time of this filing, ENVX was trading at $4.54 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1B. The 52-week trading range was $3.67 to $14.21. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.